UNC1215, an effective and specific MBT (malignant brain tumor) antagonist, binds L3MBTL3 (IC50/Kd: 40/120 nM). The selectivity of UNC1215 for L3MBTL3 is 50-fold higher versus other members of the human MBT family.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 85 | |
4 mg | In stock | $ 153 | |
8 mg | In stock | $ 229 | |
20 mg | In stock | $ 425 | |
40 mg | In stock | $ 650 |
Description | UNC1215, an effective and specific MBT (malignant brain tumor) antagonist, binds L3MBTL3 (IC50/Kd: 40/120 nM). The selectivity of UNC1215 for L3MBTL3 is 50-fold higher versus other members of the human MBT family. |
Targets&IC50 | L3MBTL3: 120 nM(Kd), L3MBTL3: 40 nM |
In vitro | CellTiter-Glo luminescent cell viability assay(Only for Reference) |
CAS No. | 1415800-43-9 |
Chemical Formula | C32H43N5O2 |
Molecular Weight | 529.729 |
Solubility | H2O: <1 mg/mL DMSO: 93 mg/mL (175.6 mM); Ethanol: 93 mg/mL (175.6 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom